Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

DIGITAL CONTENT

8 NEWS #PharmaBuzz

media
8 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

11DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 93265-81-7, Ipdr, 5-iodo-2-pyrimidinone-2'-deoxyribose, Ipd-r, 3hx21a3sqf, 1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone

Molecular Formula

C₉H₁₁IN₂O₄

Molecular Weight

338.10 g/mol

InChI Key

XIJXHOVKJAXCGJ-XLPZGREQSA-N

FDA UNII

3HX21A3SQF

Ropidoxuridine is an orally available 5-substituted 2-pyrimidinone-2'-deoxyribonucleoside analogue and prodrug of 5-iododeoxyuridine (IUdR), an iodinated analogue of deoxyuridine, with radiosensitizing activity. Upon oral administration, ropidoxuridine (IPdR) is efficiently converted to idoxuridine (IUdR) by a hepatic aldehyde oxidase. In turn, IUdR is incorporated into DNA during replication, thereby sensitizing cells to ionizing radiation by increasing DNA strand breaks. Compared to IUdR, ropidoxuridine is associated with a lower toxicity profile and improved anti-tumor activity.

1 2D Structure

Ropidoxuridine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one

2.1.2 InChI

InChI=1S/C9H11IN2O4/c10-5-2-11-9(15)12(3-5)8-1-6(14)7(4-13)16-8/h2-3,6-8,13-14H,1,4H2/t6-,7+,8+/m0/s1

2.1.3 InChI Key

XIJXHOVKJAXCGJ-XLPZGREQSA-N

2.1.4 Canonical SMILES

C1C(C(OC1N2C=C(C=NC2=O)I)CO)O

2.1.5 Isomeric SMILES

C1[C@@H]([C@H](O[C@H]1N2C=C(C=NC2=O)I)CO)O

2.2 Other Identifiers

2.2.1 UNII

3HX21A3SQF

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone

2. 5-iodo-2-pyrimidinone 2' Deoxyribonucleoside

3. 5-iodo-2-pyrimidinone-2'-deoxyribose

4. Ipdr

2.3.2 Depositor-Supplied Synonyms

1. 93265-81-7

2. Ipdr

3. 5-iodo-2-pyrimidinone-2'-deoxyribose

4. Ipd-r

5. 3hx21a3sqf

6. 1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone

7. Nsc-726188

8. 2(1h)-pyrimidinone, 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-5-iodo-

9. 1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1h)-one

10. Ropidoxuridine [usan]

11. Unii-3hx21a3sqf

12. Ropidoxuridine (inn/usan)

13. Ropidoxuridine [usan:inn]

14. 5-iodo-2-pyrimidinone 2' Deoxyribonucleoside

15. Ropidoxuridine [inn]

16. Schembl8602575

17. Chembl2103821

18. Dtxsid00239353

19. Zinc6091380

20. 5-iodo-2-pyrimidinone-2-deoxyribose

21. Db06485

22. 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one

23. Hy-13742

24. Cs-0007768

25. D08992

26. D96122

27. 265i817

28. A901121

29. Q27257237

30. 5-iodo-1-(2-deoxy-beta-d-ribofuranosyl)pyrimidin-2(1h)-one

31. 1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-5-iodopyrimidin-2(1h)-one

32. 2(1h)-pyrimidinone, 1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-5-iodo-

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₉H₁₁IN₂O₄
Molecular Weight	338.10 g/mol
XLogP3	-0.5
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	2
Exact Mass	337.97635 g/mol
Monoisotopic Mass	337.97635 g/mol
Topological Polar Surface Area	82.4 Å²
Heavy Atom Count	16
Formal Charge	0
Complexity	357
Isotope Atom Count	0
Defined Atom Stereocenter Count	3
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

Investigated for use/treatment in cancer/tumors (unspecified).

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

ABOUT THIS PAGE

Find Ropidoxuridine manufacturers, exporters & distributors on PharmaCompass

Ropidoxuridine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

DEVELOPMENTS

11 Drugs in Development

DIGITAL CONTENT

8 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

11DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?